¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18
±³À°ÀÏÀÚ : 2024-05-18
±³À°Àå¼Ò : ¼­¿ï ¼­¿ï´ëº´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) 1F ¼­¼ºÈ¯¿¬±¸È¦

±³À°ÁÖÁ¦ : Neurology of eye movements

ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾȽŰæÀÇÇÐȸ

´ã´çÀÚ : ±èÀ¯Áø
¿¬¶ôó : 02-974-8606

À̸ÞÀÏ : ksno2012@gmail.com

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 40,000¿ø  

ºñ°í »çÀüµî·Ïºñ: Àü¹®ÀÇ 30,000, ´çÀϵî·Ïºñ: Àü¹®ÀÇ 40,000 / Àü°øÀÇ ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:05~09:25 Transient monocular & binocular blindness ÀÌÁÖ¿µ(°¡Å縯ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:25~09:45 Ptosis (myogenic, N-M junction, neurogenic) ±ÇÀºÁø(Ãæ³²ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:45~10:05 Paralytic vs non-paralytic strabismus À±¼Ò¿¬(¿¬¼¼ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:05~10:25 Anisocoria  °­ÁøÁÖ(ÀüºÏÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:25~10:35 Q & A -(-)

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:35~10:50 ÈÞ½Ä -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:50~11:15 Understanding of eye movement and objective measurement ÀÓÇÑ¿õ(ÇѾçÀÇ´ë ¾È°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 11:15~11:40 Eye movement recording using virtual reality and deep-learning model È«¼º±¤(ÇѸ²ÀÇ´ë À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 11:40~12:00 Saccadic analysis: update  ÃÖ¼­¿µ(ºÎ»êÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 12:00~12:10 Q & A -(-)

½Ä»ç 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 12:10~13:10 ÃÑȸ ¹× Lunch -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:10~13:35 Afferent visual symptoms and traumatic optic neuropathy  ½ÅÇöÁø(°Ç±¹ÀÇ´ë ¾È°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:35~13:55 Efferent visual symptoms and eye movement abnormalities    ÀÌÀͼº(¼øõÇâÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:55~14:15 Post-traumatic dizziness Á¤ÀϾï(°Ç±¹ÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:15~14:25 Q & A -(-)

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:25~14:40 ÈÞ½Ä -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:40~14:55 (±¸¿¬¹ßÇ¥)ANCA-associated pachymeningitis and bilateral optic neuropathy treated with steroid pulse therapy        ±èÈ«³²(¾ÆÁÖÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:55~15:10 (±¸¿¬¹ßÇ¥)Clinical Characteristics and Genetic Analysis of Chronic Progressive External Ophthalmoplegia À̼÷¹Î(ºÎ»êÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 15:10~15:25 (±¸¿¬¹ßÇ¥)Neuro-ophthalmologic and neuro-otologic findings in spinocerebellar ataxia type 7 ±èÀç¸í(Àü³²ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 15:25~15:40 (±¸¿¬¹ßÇ¥)Hypertensive optic neuropathy    ¹ÚÁöÀ±(¿ï»êÀÇ´ë ½Å°æ°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÀü±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-05-18
´ÙÀ½±Û ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Á¦ 22Â÷ Ãá°èÁ¤±â½ÉÆ÷Áö¾ö ¹× ÃÑȸ : 2024-05-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 10 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 12 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 13 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 9 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 13 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 17 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 12 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 6 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 9 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 14 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 14 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 7 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 20 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 14 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 12 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷